BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Moreno-Gonzalez M, Beraza N. The Role of the Microbiome in Liver Cancer. Cancers (Basel) 2021;13:2330. [PMID: 34066064 DOI: 10.3390/cancers13102330] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
Number Citing Articles
1 Xiong Y, Wu L, Shao L, Wang Y, Huang Z, Huang X, Li C, Wu A, Liu Z, Fan X, Zhou P. Dynamic Alterations of the Gut Microbial Pyrimidine and Purine Metabolism in the Development of Liver Cirrhosis. Front Mol Biosci 2022;8:811399. [DOI: 10.3389/fmolb.2021.811399] [Reference Citation Analysis]
2 Ni Y, Lu M, Xu Y, Wang Q, Gu X, Li Y, Zhuang T, Xia C, Zhang T, Gou X, Zhou M. The Role of Gut Microbiota-Bile Acids Axis in the Progression of Non-alcoholic Fatty Liver Disease. Front Microbiol 2022;13:908011. [DOI: 10.3389/fmicb.2022.908011] [Reference Citation Analysis]
3 Shen S, Khatiwada S, Behary J, Kim R, Zekry A. Modulation of the Gut Microbiome to Improve Clinical Outcomes in Hepatocellular Carcinoma. Cancers (Basel) 2022;14:2099. [PMID: 35565229 DOI: 10.3390/cancers14092099] [Reference Citation Analysis]
4 Zhang M, Serna-Salas S, Damba T, Borghesan M, Demaria M, Moshage H. Hepatic stellate cell senescence in liver fibrosis: Characteristics, mechanisms and perspectives. Mech Ageing Dev 2021;199:111572. [PMID: 34536446 DOI: 10.1016/j.mad.2021.111572] [Reference Citation Analysis]
5 Zhang L, Xie Z, Yu H, Du H, Wang X, Cai J, Qiu Y, Chen R, Jiang X, Liu Z, Li Y, Chen T. TLR2 inhibition ameliorates the amplification effect of LPS on lipid accumulation and lipotoxicity in hepatic cells. Ann Transl Med 2021;9:1429. [PMID: 34733981 DOI: 10.21037/atm-21-4012] [Reference Citation Analysis]
6 Garcia-Gutierrez E, Cotter PD. Relevance of organ(s)-on-a-chip systems to the investigation of food-gut microbiota-host interactions. Crit Rev Microbiol 2021;:1-26. [PMID: 34591726 DOI: 10.1080/1040841X.2021.1979933] [Reference Citation Analysis]